• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类长期异基因骨髓移植受者中具有可变端粒缩短的多克隆造血。

Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients.

作者信息

Mathioudakis G, Storb R, McSweeney P A, Torok-Storb B, Lansdorp P M, Brümmendorf T H, Gass M J, Bryant E M, Storek J, Flowers M E, Gooley T, Nash R A

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

出版信息

Blood. 2000 Dec 1;96(12):3991-4.

PMID:11090091
Abstract

Donor-derived hematopoiesis was assessed in 17 patients who received allogeneic marrow grafts from HLA-matched siblings between 1971 and 1980. Complete blood counts were normal or near normal in all patients except one. Chimerism analyses, using either dual-color XY-chromosome fluorescence in situ hybridization (FISH) or analysis of variable number tandem repeat loci, indicated that 15 out of 16 patients had greater than 97% donor-derived hematopoiesis, whereas 1 patient had indeterminate chimerism. All 12 recipients of grafts from female donors exhibited polyclonal hematopoiesis by X-linked clonal analysis with the use of molecular probes. Of the 17 recipients, 9 exhibited a less than 1.0-kilobase shortening of granulocyte telomere length compared with their respective donors, according to terminal restriction fragment analysis or flow-FISH with a fluorescein-labeled peptide nucleic acid probe. These data suggest that under standard transplantation conditions, the stem cell proliferative potential is not compromised during hematopoietic reconstitution. (Blood. 2000;96:3991-3994)

摘要

对1971年至1980年间接受来自HLA匹配同胞的异基因骨髓移植的17例患者进行了供体来源造血的评估。除1例患者外,所有患者的全血细胞计数均正常或接近正常。使用双色XY染色体荧光原位杂交(FISH)或可变数目串联重复序列位点分析进行的嵌合分析表明,16例患者中有15例供体来源造血大于97%,而1例患者的嵌合情况不确定。通过使用分子探针的X连锁克隆分析,所有12例接受女性供体移植的受者均表现出多克隆造血。根据末端限制片段分析或使用荧光素标记肽核酸探针的流式FISH,17例受者中有9例与各自供体相比,粒细胞端粒长度缩短小于1.0千碱基。这些数据表明,在标准移植条件下,造血重建过程中干细胞增殖潜能未受损害。(《血液》。2000年;96:3991 - 3994)

相似文献

1
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients.人类长期异基因骨髓移植受者中具有可变端粒缩短的多克隆造血。
Blood. 2000 Dec 1;96(12):3991-4.
2
Limited telomere shortening in hematopoietic stem cells after transplantation.移植后造血干细胞中端粒缩短有限。
Ann N Y Acad Sci. 2001 Jun;938:1-7; discussion 7-8. doi: 10.1111/j.1749-6632.2001.tb03568.x.
3
Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion.异基因骨髓移植受者的长期随访显示,端粒没有进行性缩短,也没有证据表明造血干细胞耗竭。
Br J Haematol. 2002 Feb;116(2):491-6. doi: 10.1046/j.0007-1048.2001.03283.x.
4
Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation.
N Engl J Med. 1989 Jun 22;320(25):1655-61. doi: 10.1056/NEJM198906223202504.
5
In vivo telomere dynamics of human hematopoietic stem cells.人类造血干细胞的体内端粒动力学
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13782-5. doi: 10.1073/pnas.94.25.13782.
6
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.异基因淋巴细胞造血移植后完全和混合供体嵌合体的建立:2001年国际骨髓移植登记处与美国血液和骨髓移植学会联合会议上一个研讨会的建议
Biol Blood Marrow Transplant. 2001;7(9):473-85. doi: 10.1053/bbmt.2001.v7.pm11669214.
7
Quantitative analysis of mixed chimerism following allogeneic bone marrow transplantation using telomere flow-FISH.
Ann Hematol. 2003 Jul;82(7):416-22. doi: 10.1007/s00277-003-0659-4. Epub 2003 May 24.
8
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.
Lancet. 1998 Jan 17;351(9097):178-81. doi: 10.1016/S0140-6736(97)08256-1.
9
Changes of telomere length in children after hematopoietic stem cell transplantation.造血干细胞移植后儿童端粒长度的变化
Bone Marrow Transplant. 1998 Jan;21(2):167-71. doi: 10.1038/sj.bmt.1701060.
10
Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant.在接受性别不匹配的异基因骨髓移植的重型再生障碍性贫血患者中,人间充质干细胞并非供体来源。
J Hematother Stem Cell Res. 2002 Dec;11(6):977-84. doi: 10.1089/152581602321080646.

引用本文的文献

1
Allogeneic stem cell transplantation from variant-carrying family donors leads to long-term engraftment in Telomere Biology Disorders.来自携带变异体的家族供体的异基因干细胞移植可导致端粒生物学障碍的长期植入。
Blood Cancer J. 2025 Aug 25;15(1):142. doi: 10.1038/s41408-025-01348-z.
2
Inherited Telomere Biology Disorders: Pathophysiology, Clinical Presentation, Diagnostics, and Treatment.遗传性端粒生物学障碍:病理生理学、临床表现、诊断与治疗
Transfus Med Hemother. 2024 Jul 30;51(5):292-309. doi: 10.1159/000540109. eCollection 2024 Oct.
3
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors.
与供体相比,长期接受异基因造血细胞的受者呈现出类似衰老的表型。
Immun Ageing. 2022 Nov 2;19(1):51. doi: 10.1186/s12979-022-00308-6.
4
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia.再生障碍性贫血患者的表观遗传衰老与造血干细胞移植
Transplant Cell Ther. 2021 Apr;27(4):313.e1-313.e8. doi: 10.1016/j.jtct.2021.01.013. Epub 2021 Jan 16.
5
Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.雄激素衍生物达那唑、羟甲烯龙和诺龙对先天性角化不良症患者原代造血细胞端粒酶活性的可比影响。
Int J Mol Sci. 2020 Sep 29;21(19):7196. doi: 10.3390/ijms21197196.
6
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.重型再生障碍性贫血:异基因骨髓移植作为一线治疗。
Blood Adv. 2018 Aug 14;2(15):2020-2028. doi: 10.1182/bloodadvances.2018021162.
7
Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.供者年龄对异基因造血细胞移植后结局的影响。
Biol Blood Marrow Transplant. 2015 Jan;21(1):105-12. doi: 10.1016/j.bbmt.2014.09.021. Epub 2014 Sep 30.
8
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.造血干细胞移植后,年龄调整的受者移植前端粒长度与治疗相关死亡率。
Blood. 2012 Oct 18;120(16):3353-9. doi: 10.1182/blood-2012-01-403337. Epub 2012 Sep 4.
9
Isolation and therapeutic potential of human haemopoietic stem cells.人造血干细胞的分离与治疗潜力。
Cytotechnology. 2003 Mar;41(2-3):111-31. doi: 10.1023/A:1024822722285.
10
The role of telomere biology in bone marrow failure and other disorders.端粒生物学在骨髓衰竭及其他病症中的作用。
Mech Ageing Dev. 2008 Jan-Feb;129(1-2):35-47. doi: 10.1016/j.mad.2007.11.002. Epub 2007 Nov 19.